REBANIFLY Trademark

Trademark Overview

On Wednesday, February 8, 2017, a trademark application was filed for REBANIFLY with the United States Patent and Trademark Office. The USPTO has given the REBANIFLY trademark a serial number of 87328617. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, October 3, 2025. This trademark is owned by Shanghai Henlius Biotech, Inc.. The REBANIFLY trademark is filed in the Pharmaceutical Products category with the following description:

Anti-tumor drugs; anti-tumor drugs and drugs for treating autoimmune diseases
rebanifly

General Information

Serial Number87328617
Word MarkREBANIFLY
Filing DateWednesday, February 8, 2017
Status710 - CANCELLED - SECTION 8
Status DateFriday, October 3, 2025
Registration Number5700187
Registration DateTuesday, March 19, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 1, 2019

Trademark Statements

Goods and ServicesAnti-tumor drugs; anti-tumor drugs and drugs for treating autoimmune diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, October 3, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameShanghai Henlius Biotech, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressShanghai 201203
CN
Party NameShanghai Henlius Biotech, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressShanghai 201203
CN
Party NameShanghai Henlius Biotech, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressShanghai 201203
CN

Trademark Events

Event DateEvent Description
Thursday, May 4, 2017NON-FINAL ACTION WRITTEN
Monday, February 13, 2017NEW APPLICATION ENTERED
Monday, February 13, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, May 3, 2017ASSIGNED TO EXAMINER
Thursday, May 4, 2017NON-FINAL ACTION E-MAILED
Thursday, May 4, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, November 1, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, November 1, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, November 2, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, November 4, 2017SUSPENSION LETTER WRITTEN
Saturday, November 4, 2017LETTER OF SUSPENSION E-MAILED
Saturday, November 4, 2017NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, May 4, 2018SUSPENSION INQUIRY WRITTEN
Friday, May 4, 2018INQUIRY TO SUSPENSION E-MAILED
Friday, May 4, 2018NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Friday, November 2, 2018TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, November 2, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 13, 2018ASSIGNED TO LIE
Monday, November 19, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, November 19, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 19, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 19, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 12, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 1, 2019PUBLISHED FOR OPPOSITION
Tuesday, January 1, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 15, 2019TEAS POST PUBLICATION AMENDMENT RECEIVED
Thursday, January 24, 2019ASSIGNED TO PETITION STAFF
Friday, January 25, 2019WITHDRAWN FROM ISSUE - PETITIONS OFFICE REQUEST
Friday, January 25, 2019POST PUBLICATION AMENDMENT - ENTERED
Saturday, January 26, 2019TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, January 26, 2019APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, March 19, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, March 19, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, October 3, 2025CANCELLED SEC. 8 (6-YR)

Related Keywords

rebanifly drugs tumor anti diseases treating autoimmune